WDH Soars: Q1 Revenue Up 64.8% Year-Over-Year!

Company Overview & Q1 2026 Highlights

Waterdrop Inc. (NYSE: WDH) is a Chinese financial technology platform focused on online insurance brokerage and medical crowdfunding services. The company connects users with insurers through its digital marketplace and operates a crowdfunding platform that helps patients raise funds for medical bills. After an IPO in 2021, Waterdrop underwent a strategic shift toward profitability in 2022 by cutting costs and introducing fees on its fundraising platform. This strategy has paid off: by Q1 2026, Waterdrop achieved RMB1.242 billion in net operating revenue (≈US$180 million) for the quarter – a 64.8% jump year-over-year (www.prnewswire.com). Most of this growth is driven by its core insurance brokerage business: insurance-related income surged 74.1% YoY to RMB1.146 billion (www.prnewswire.com). The company has now posted five consecutive quarters of GAAP profitability, with Q1 2026 operating profit reaching RMB80.0 million (up 5.3% YoY) (www.prnewswire.com). Net profit for Q1 2026 was RMB98.4 million (US$14.3 million), a slight decline from RMB108.2 million a year prior due to a substantial increase in marketing investments (www.prnewswire.com). Even so, Waterdrop’s Q1 results demonstrate robust top-line expansion and continued positive earnings.

Ni
Fast Spotlight: Nickel — National Security Metal
Dr. Skousen's exclusive report names the tiny U.S. miner that could attract government investment and big buyout interest.

Get My Copy

Includes 3 bonus reports

Quick bullets: • Tesla 75k MT deal • $137M in federal grants • Rio Tinto partnership • Robert Friedland backing • Potential buyout runway

Operationally, Waterdrop’s user base and offerings continue to expand. As of March 31, 2026, its medical crowdfunding platform had attracted 494 million cumulative donors, contributing RMB68.8 billion toward 3.47 million patients’ campaigns (ir.waterdrop-inc.com). The insurance marketplace offered over 1,300 products, including new “critical illness” and specialized policies tailored for underserved segments. First-year premiums (FYP) generated via the platform rose to RMB2.09 billion in Q1 2025 (up 19% YoY) (ir.waterdrop-inc.com), reflecting solid growth in insurance distribution. Management has also highlighted investments in technology (AI customer service bots, digital clinical trial matching) to improve efficiency and create new revenue streams (ir.waterdrop-inc.com) (ir.waterdrop-inc.com). By Q4 2025, Waterdrop’s revenue growth had dramatically accelerated – Q4 2025 operating revenue more than doubled year-over-year (+105.5%) (marketchameleon.com) – setting the stage for the strong Q1 2026 performance.

Dividend Policy & Shareholder Returns

Waterdrop is a growth-oriented tech company, but it has begun returning cash to shareholders through dividends and buybacks as profitability improves. The company does not pay a regular quarterly dividend, but it initiated special cash dividends tied to annual results. For fiscal 2023, Waterdrop’s board declared a US$0.04 per ADS special dividend (US$0.004 per ordinary share) (www.nasdaq.com). This was paid in early 2024 and amounted to roughly $10 million distributed to investors. Following another year of strong earnings, Waterdrop announced a second cash dividend in 2024. By Q1 2026, the company reported it had “recently paid a cash dividend of approximately US$10.8 million” as part of its shareholder return program (www.prnewswire.com). This implies a dividend of roughly $0.05 per ADS for the latest year, which at the recent share price equates to a ~3% annual yield. While these payouts have been labeled as special distributions, the consecutive yearly dividends in 2023–2025 suggest management’s intent to share profits with shareholders on an ongoing basis (contingent on financial performance). Importantly, WDH’s dividends are well-supported by earnings and cash flow – for context, full-year 2024 net income was RMB368 million (~US$53 million) (finance.sina.com.cn), making the ~$10 million cash dividend a conservative ~20% payout ratio. Moreover, Waterdrop generates substantial free cash flow; it has consistently reported positive operating cash flow alongside its steady profits (www.nasdaq.com). Traditional REIT metrics like FFO/AFFO are not applicable here, as Waterdrop is not a REIT and does not own cash-flowing real estate. Instead, its dividends are paid out of net income and accumulated cash on hand.

Andy Howard — Builder, Investor, Grid Insider

Track record: 840% | 1,064% | 4,040%. Andy shows exactly how he’s positioning for the biggest forced migration in history.

Special: $179
Model Portfolio
Buy/sell targets, position sizes, and when to take profits — step-by-step.
Instant Reports
Get “Digital Oil” plus three bonus reports the minute you join.
Dive into Andy’s research — start with a free report and the model portfolio.

In addition to dividends, Waterdrop has aggressively repurchased its own shares. The company launched buyback programs in 2021–2023 and by May 2026 had bought back ~61.8 million ADSs from the open market, spending about US$120.1 million in total (www.prnewswire.com). This is a significant capital return (nearly 20% of its market cap) and reflects management’s confidence in the company’s value. These repurchases have reduced the outstanding share count, amplifying the benefit of earnings growth on a per-share basis. Overall, Waterdrop’s nascent dividend-and-buyback strategy signals a shareholder-friendly approach: it is reinvesting in growth and returning excess cash, a balance that could attract both growth investors and yield-focused investors if continued. The dividend yield remains modest (low- to mid-single digits), but any initiation of a regular payout or increase in special dividends would be a positive catalyst for income-oriented shareholders.

Leverage, Debt & Coverage

Waterdrop carries very little debt, resulting in a strong balance sheet with net cash. The company’s business model is asset-light – it earns commissions and fees rather than holding insurance liabilities – so it has not needed significant borrowings to fund operations. As of December 31, 2025, Waterdrop’s total liabilities were ¥2.79 billion (US$279 million) against ¥10.16 billion in total assets (quotes.sina.com.cn). Only a tiny portion of those liabilities are interest-bearing debt: short-term debt (including current portion of long-term debt) was RMB82.8 million (~US$8.3 million), and long-term debt was just RMB18.1 million (~US$1.8 million) (quotes.sina.com.cn). These debt levels are negligible relative to an equity base of ~US$737 million (quotes.sina.com.cn). In fact, Waterdrop’s cash and short-term investments totaled RMB2.88 billion (US$418 million) as of Q1 2026, vastly exceeding its debt (www.stocktitan.net). The company has essentially no net leverage – it is in a net cash position – and thus faces minimal refinancing or default risk. There are no large debt maturities to worry about; the small amount of debt on the books could be easily repaid or rolled over given the firm’s cash reserves. Management’s use of cash has been discretionary (dividends, buybacks, investments), not driven by debt obligations.

Because debt is so low, coverage ratios are extremely strong. Waterdrop’s operating profits and EBITDA comfortably cover its token interest expense – in fact, the company’s interest income from cash on hand far outweighs any interest costs. In Q1 2025, Waterdrop earned RMB33.8 million (US$4.7 M) in interest income from its cash and investments (ir.waterdrop-inc.com), which indicates it had net interest income. This means traditional metrics like interest coverage (EBIT/interest) are essentially off the charts – the company has no issue meeting interest obligations when it’s actually a net lender/creditor earning interest. Even if we consider fixed charges, Waterdrop’s Q1 2026 operating profit (RMB80 M) alone is more than 30× the total interest expense of the prior year (interest expense was effectively zero, while interest income was ~RMB130 M for full-year 2025) (ir.waterdrop-inc.com). In short, Waterdrop’s balance sheet is very conservatively managed, with ample liquidity and negligible leverage. This provides financial flexibility and a buffer against economic or regulatory shocks. It also positions the company to invest in growth opportunities without resorting to risky borrowing. Investors can take comfort that Waterdrop’s expansion is not built on debt – a key positive in an uncertain macro environment.

Valuation & Comparables

Despite the strong growth and improving profitability, WDH shares appear undervalued on several metrics. As of mid-2026, the stock trades around $1.40–$1.50 per ADS, which gives a market capitalization of roughly $600–650 million (www.bamsec.com). For context, Waterdrop generated ¥4.13 billion in revenue in 2025 (≈$583 million) (www.wallstreetzen.com) (craft.co), meaning the stock is valued at only about 1.1× trailing annual revenue. On an earnings basis the multiples are also low: 2024 net income was ¥368 M (~$53 M) (finance.sina.com.cn) and 2025 net profit is on track to be higher (though Q1 2026 profit dipped, full-year 2025 likely exceeded $55 M). That puts WDH at roughly 11–12× trailing earnings, a modest P/E for a company that just grew revenue 65%+. Even if we factor in the surge in marketing spend (which tempered recent net margins), Waterdrop’s PEG ratio (price/earnings-to-growth) seems very attractive given revenue and profit have been growing at double- or triple-digit rates. Another angle: Waterdrop’s book value per share is about $2.04 (US GAAP equity of $737 M over ~360 M ADS equivalents) (quotes.sina.com.cn). Thus, the stock trades at roughly 0.7x–0.8x price-to-book, implying the market values the company at less than its liquidation value. In other words, investors buying at ~$1.50 are getting Waterdrop’s high-growth business for a significant discount to its accounting book value – and effectively paying nothing for its future growth prospects.

Comparable companies underscore WDH’s value gap. For example, Fanhua Inc. (FANH), a Chinese insurance broker with slower growth, has historically traded around 1.0–1.5× sales and over 10× earnings. U.S. “insurtech” firms like Lemonade (LMND) or Oscar Health (OSCR) often have no profits and trade at multiple times sales, yet Waterdrop – which is profitable – trades near 1× sales (www.wallstreetzen.com). Even relative to Chinese internet peers, Waterdrop’s multiples are low: many mid-cap Chinese tech firms trade at high-teens P/Es or above. The cautious valuation likely reflects investor concerns (China regulatory risk, the reliability of Waterdrop’s earnings, etc., discussed below). It may also reflect low analyst coverage and the small-cap nature of WDH – it flies under the radar. If Waterdrop can sustain its growth trajectory and navigate risks, there is considerable valuation upside. At a P/E of 15–20 (still conservative for its growth), the stock would trade well above $2.00. Additionally, with over $400 M in cash on the balance sheet, Waterdrop’s enterprise value is even lower (~$200–250 M net of cash), making EV/EBITDA and EV/Sales ratios strikingly cheap. In summary, WDH is valued like a risky, no-growth entity, yet it’s delivering high growth and generating cash – a disconnect that could correct as the company proves itself.

Risks & Red Flags

While Waterdrop’s financial performance is impressive, investors should be aware of several risks and potential red flags:

Regulatory and Policy Risk (China): Waterdrop operates in China’s regulated insurance and internet sectors, and any policy changes could impact its business. In mid-2021, Chinese regulators tightened rules on online insurance marketing and crowdfunding, which forced Waterdrop to suspend certain user acquisition tactics and to introduce fees on its crowdfunding platform (ir.waterdrop-inc.com) (ir.waterdrop-inc.com). Future regulations could further limit how Waterdrop markets insurance or cap the fees it charges (e.g. the 3% crowdfunding service fee). The company’s Variable Interest Entity (VIE) structure – used to bypass foreign ownership restrictions – adds another layer of regulatory uncertainty, as Beijing has scrutinized overseas-listed tech firms. A crackdown or shift in regulatory stance could materially affect Waterdrop’s operations or its ability to remain listed abroad.

Surging Expenses & Profitability Concerns: Waterdrop’s recent growth has been fueled by a massive increase in marketing spend. Sales and marketing expenses jumped +213.8% YoY in Q1 2026 to RMB541 M (www.prnewswire.com), as the company poured money into third-party traffic channels (like ads on WeChat, Douyin/TikTok, etc.) to acquire users. This caused net profit to dip despite higher revenue (www.prnewswire.com). If such heavy spending continues, there’s a risk that Waterdrop’s profit margins will remain thin or turn negative, undermining the profitability turnaround it achieved since 2022. It’s a classic growth-versus-profit trade-off: management is choosing to reinvest aggressively in growth, but if those marketing dollars don’t yield strong customer lifetime value, returns could disappoint. Additionally, high marketing dependency indicates competitive pressure – Waterdrop may be fighting for users with deep-pocketed rivals and must pay up for traffic. Investors should monitor whether the customer acquisition costs come down over time or if Waterdrop becomes locked into high spending just to maintain growth.

Reliance on Partners (Platform Risk): Waterdrop’s ecosystem depends on larger partners and platforms. For insurance products, it partners with many insurance carriers – if any major insurer cuts ties or reduces commissions, Waterdrop’s revenue could suffer. The medical crowdfunding side relies heavily on social sharing, especially via Tencent’s WeChat. (Notably, Tencent was an early investor in Waterdrop and historically a source of user traffic.) Any changes in WeChat’s policies or algorithms – or a strategic rift with Tencent – could reduce Waterdrop’s reach. There’s also concentration risk in marketing: a large portion of user acquisition spend likely goes to a few dominant online platforms. This gives those platforms (Tencent, ByteDance, etc.) significant power – they could raise advertising prices or impose restrictions that squeeze Waterdrop’s economics.

Reputation and Ethical Risks: Waterdrop’s mission-driven image (“positive social impact” in financing healthcare) is a double-edged sword. On one hand, it attracts users; on the other, any scandal or misuse of the platform could severely damage its reputation. In the past, critics have raised concerns about fraudulent fundraising campaigns or misuse of donated funds in China’s medical crowdfunding space. Waterdrop has implemented stricter risk controls and verification (now covering 92% of cities, with checks on housing, income, etc. for campaign applicants (ir.waterdrop-inc.com)), but the risk of a high-profile fraud or public backlash remains. Similarly, charging fees on charitable donations could draw criticism; Waterdrop must balance monetization with social responsibility. Negative publicity or public mistrust could drive users (and regulators) away, directly impacting growth.

Shareholder Structure and Market Risks: As an ADR of a Chinese issuer, WDH carries the typical risks of U.S.-listed Chinese stocks – potential delisting risk (if U.S.–China audit disputes resurface), currency fluctuation (earnings in RMB but stock in USD), and often low liquidity. The stock’s daily trading volume is relatively light, which can lead to high volatility. Furthermore, Waterdrop’s co-founder/CEO Shen Peng likely maintains significant voting control through a dual-class share structure (Class B shares with super-voting rights), meaning ordinary shareholders have limited say. There’s also overhang risk if early investors (like Tencent or venture backers) decide to sell their stakes as lock-ups expire or as part of portfolio rebalancing – such sales could put short-term pressure on the stock.

Considering these factors, investors should view Waterdrop’s growth story in light of its risk profile. The company must carefully navigate regulatory waters and prove that its recent marketing-fueled growth can translate into sustainable profits. The imbalance between soaring revenue and soaring costs is a key risk to watch in upcoming quarters. Waterdrop’s ability to manage growth without eroding its margins or mission will be crucial to its long-term investment case.

Open Questions

Waterdrop’s recent results raise several important questions for the future:

Can explosive revenue growth continue? Q1’s 64.8% YoY revenue jump is impressive, but was it an anomaly driven by post-pandemic recovery and marketing blitz, or can Waterdrop sustain high double-digit growth? Investors will want to see if subsequent quarters (Q2–Q4 2026) continue the momentum, especially as comps get tougher.

Will marketing ROI justify the spend? With sales/marketing outlays up 3× year-on-year (www.prnewswire.com), how much new business is Waterdrop actually capturing? Key metrics like user acquisition cost, conversion rate, and customer lifetime value are crucial. An open question is whether Waterdrop can eventually moderate its marketing spend and still grow – i.e. achieve operating leverage – or if growth is overly dependent on burning cash for ads.

What is the long-term profit margin profile? Management has proven Waterdrop can be profitable (net margins were ~8-10% in 2022–24). But with the current growth push, net margin fell to ~8% in Q1 2026 (www.prnewswire.com). Once the business matures, can Waterdrop expand margins (through higher take rates, operating efficiency, etc.)? Or are there structural limits due to competition and the low-margin nature of insurance brokerage? Clarity on a sustainable margin range will help in valuing the company.

How will the dividend policy evolve? Thus far, dividends have been small annual specials. Going forward, will Waterdrop formalize a regular dividend (e.g. semi-annual or quarterly) given its strong cash position? The company paid ~US$10.8M in dividends in the last year (www.prnewswire.com), which is easily manageable – so there is room to increase payouts if growth investments don’t require all surplus cash. Investors are watching if Waterdrop might raise the dividend or repeat special dividends consistently, effectively establishing a yield stock profile in addition to growth.

Are there new growth vectors on the horizon? Waterdrop has hinted at expanding services – e.g. “digital clinical trial” recruitment revenue grew 11.5% YoY (ir.waterdrop-inc.com). Will this or other “adjacent” segments become material to revenue? Also, might Waterdrop seek growth beyond China (international expansion) or in adjacent fintech areas? Any move to broaden its business could diversify revenue but also introduces execution risk.

What is the endgame with big tech partners? Given Tencent’s historical involvement, one open question is whether Waterdrop remains independent long-term or could be acquired by a larger insurance or tech company. Conversely, if key partners launch similar services (for instance, if Alipay or WeChat built their own medical crowdfunding or insurance marketplace), how would Waterdrop fend off direct competition?

Each of these questions will shape Waterdrop’s trajectory. WDH’s stock “soaring” on revenue growth is a great headline, but the company’s ability to address these open issues will determine if that performance is durable. Investors should keep a close eye on management’s commentary and the next few earnings reports for clues on these fronts. Waterdrop has delivered a remarkable turnaround and growth spurt – now the focus shifts to execution, sustainability, and strategic clarity as the company navigates its next phase.

Sources: Waterdrop Inc. Q1 2026 earnings release (www.prnewswire.com) (www.prnewswire.com); Q1 2025 and Q4 2023 results from Waterdrop IR (ir.waterdrop-inc.com) (www.nasdaq.com); Company balance sheet data (quotes.sina.com.cn) (quotes.sina.com.cn); Stock metrics from market data (www.bamsec.com) (www.wallstreetzen.com); and news reports on Waterdrop’s dividend and growth initiatives (www.nasdaq.com) (www.prnewswire.com).

For informational purposes only; not investment advice.